NCT02680535
MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue No drug interventions treatment Not Available completed NCT04240639
An Extension Study MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue No drug interventions treatment Not Available active_not_recruiting NCT03149861
Detection of Clinically Significant Prostate Cancer With 18F-DCFPyL PET/MR No drug interventions diagnostic Not Available active_not_recruiting NCT05422911
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer. treatment 2 not_yet_recruiting NCT01553188
AMG 386 and Abiraterone for Advanced Prostate Cancer treatment 2 completed NCT01819285
Early Compared With Delayed Hormone Therapy in Treating Patients With Nonmetastatic Prostate Cancer No drug interventions treatment 3 completed NCT03322020
Androgen Deprivation Therapy, External Beam Radiotherapy and Stereotactic Radiosurgery Boost for Prostate Cancer No drug interventions treatment 1 / 2 completed NCT03344757
Health Gatherings - For Your Health After Cancer No drug interventions supportive_care Not Available active_not_recruiting NCT02759744
Fusion Guided Focal Laser Ablation of Prostate Cancer No drug interventions device_feasibility Not Available suspended NCT03173924
18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer diagnostic 2 active_not_recruiting NCT03181867
18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer diagnostic 2 enrolling_by_invitation NCT04633252
M9241 in Combination With Docetaxel in Adults With Metastatic Castration Sensitive and Castration Resistant Prostate Cancer treatment 1 / 2 recruiting NCT00970203
Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer treatment 2 completed NCT03572387
A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local Treatment treatment 2 completed NCT00910754
A QT/QTc and Multi-Dose Pharmacokinetic Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer treatment 1 completed NCT00474383
An Safety and Efficacy Study of Abiraterone Acetate in Participants With Advanced Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy treatment 2 completed NCT01477749
Sipuleucel-T Manufacturing Demonstration Study Not Available 2 completed NCT03388619
Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy No drug interventions treatment 1 active_not_recruiting NCT01695135
A Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetaxel-Based Chemotherapy treatment 3 completed NCT01017939
A Drug-Drug Interaction Study of Abiraterone Acetate Plus Prednisone With Dextromethorphan and Theophylline in Patients With Metastatic Castration-Resistant Prostate Cancer treatment 1 completed NCT01424930
A Study to Determine the Short-Term Safety of Continuous Dosing of Abiraterone Acetate and Prednisone in Modified Fasting and Fed States to Patients With Metastatic Castration-Resistant Prostate Cancer treatment 2 completed NCT01284920
A Study of MDV3100 to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of in Prostate Cancer Patients treatment 1 / 2 completed NCT03531827
Combining CRLX101, a Nanoparticle Camptothecin, With Enzalutamide in People With Progressive Metastatic Castration Resistant Prostate Cancer Following Prior Enzalutamide Treatment treatment 2 terminated NCT01228760
A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Castration-Resistant Prostate Cancer No drug interventions treatment 1 completed NCT00102544
Use of Tracking Devices to Locate Abnormalities During Invasive Procedures No drug interventions device_feasibility Not Available enrolling_by_invitation NCT00298155
Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer treatment 2 completed NCT02649855
Docetaxel and PROSTVAC for Metastatic Castration-Sensitive Prostate Cancer treatment 2 completed NCT04703543
Evaluating the Role of Both PSMA and 64Cu-PET/CT Total Body in Patients With Locally Relapsed Prostate Cancer No drug interventions diagnostic Not Available completed NCT00425503
PS-341 Followed by Removal of Prostate for Those With Prostate Cancer treatment 2 completed NCT02334579
Stereotactic Body Radiotherapy for Stage I-III Prostate Cancer No drug interventions treatment Not Available recruiting NCT01217697
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer Not Available Not Available approved_for_marketing NCT01692483
Post-marketing Surveillance Study on the Safety and Effectiveness of Abiraterone Acetate Among Adult Filipino Male Patients With Advanced Metastatic Castration Resistant Prostate Cancer Not Available Not Available withdrawn NCT01664728
An Expanded Access Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer Who Have Completed Clinical Study COU-AA-001 treatment 1 completed NCT01834209
A Study of Abiraterone Acetate Plus Prednisone in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer Not Available Not Available no_longer_available NCT00972309
A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer No drug interventions treatment 1 completed NCT01715285
A Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC) treatment 3 completed NCT01581749
Evaluation of Truebeam for Low-Intermediate Risk Prostate Cancer No drug interventions treatment 4 unknown_status NCT02582749
Androgen Deprivation Therapy +/- Radium-223 Dichloride in Metastatic Prostate Cancer With Bone Metastases treatment 2 terminated NCT00643617
CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry No drug interventions treatment Not Available completed NCT00600535
A Pharmacokinetics Study to Assess Abiraterone Acetate Capsule and Tablet Formulations in Patients With Prostate Cancer treatment 1 completed NCT02319239
Prostate Cancer Stereotactic Radiotherapy No drug interventions treatment Not Available completed NCT00167648
Neoadjuvant Estradiol or Androgen Deprivation in Clinically Localized Prostate Cancer treatment 2 completed NCT02900248
CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice No drug interventions Not Available Not Available terminated NCT00999960
Study to Evaluate the Clinical Impact of a Laparoscopic Radical Prostatectomy Simulator No drug interventions other Not Available suspended NCT00643994
CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution No drug interventions treatment Not Available completed NCT03685591
PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors treatment 1 terminated NCT05577689
Novel Therapy Target in Metastatic Prostate Cancer No drug interventions Not Available Not Available not_yet_recruiting NCT00544440
An Observational Study of Continuous Oral Dosing of Abiraterone Acetate in Castration-Resistant Prostate Cancer Patients Evaluating Androgens and Steroid Metabolites in Bone Marrow Plasma treatment 2 completed NCT00473746
Abiraterone Acetate Dose-Escalation Study in Hormone Refractory Prostate Cancer treatment 1 / 2 completed NCT01400555
A Safety Study of Abiraterone Acetate Administered in Combination With Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) No drug interventions treatment 1 completed NCT02652000
Quality of Life After Permanent Interstitial Iodine Seed Prostate Brachytherapy No drug interventions Not Available Not Available completed NCT01371513
Korean Practice Patterns for Screening PCA(Prostate Cancer) No drug interventions Not Available Not Available completed NCT00883909
ARI103094-Follow-Up Study for REDUCE Study Subjects Not Available Not Available completed NCT00056407
"REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk prevention 3 completed NCT04249947
P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) treatment 1 active_not_recruiting NCT00363311
Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men treatment 4 completed NCT00148928
Safety & Activity of P501-AS15 Vaccine as a First-line Treatment for Patients With Hormone-sensitive Prostate Cancer Who Show Rising PSA No drug interventions prevention 1 completed NCT02381990
MRI/Ultrasound Fusion Guided Prostate Cryotherapy No drug interventions Not Available Not Available recruiting NCT05241236
MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer No drug interventions Not Available Not Available recruiting NCT02349139
Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer No drug interventions treatment 1 terminated NCT02153918
Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy No drug interventions treatment 2 completed NCT01337258
Economic Analyses of the REDUCE Trial Not Available Not Available completed NCT00558363
ARTS - AVODART After Radical Therapy For Prostate Cancer Study treatment 2 completed NCT00470834
Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy treatment 4 completed NCT03493945
Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1) treatment 1 / 2 active_not_recruiting NCT05252390
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT04852224
Strength, Aging, and Memory in Prostate Cancer No drug interventions Not Available Not Available completed NCT02809690
18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer diagnostic 1 terminated NCT03232164
PSMA-based 18F-DCFPyL PET/CT and PET/MRI Pilot Studies in Prostate Cancer diagnostic 0 recruiting NCT03321864
Capture of Prostatic Trans-rectal Ultrasound Scans for Research No drug interventions basic_science Not Available suspended NCT04124107
Unfavorable MRI But Favorable 68Ga-PSMA PET/MRI for Primary Prostate Cancer Detection No drug interventions diagnostic Not Available unknown_status NCT04053842
Multi-modality Imaging (PCa) Using Sodium MRI and PSMA PET in Men Pre-prostatectomy No drug interventions diagnostic 2 recruiting NCT04045717
Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0 No drug interventions treatment 2 active_not_recruiting NCT02787434
Addressing Prostate Cancer Information Disparities With eHealth Technology No drug interventions screening Not Available completed NCT04541225
Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors No drug interventions treatment 1 terminated NCT02485665
Efficacy of Extracorporeal Biofeedback Device for Post-prostatectomy Incontinence No drug interventions supportive_care Not Available unknown_status NCT01630967
Efficacy Study of Switching to a Lutenizing Hormone-releasing Hormone (LHRH) Antagonist From a LHRH Agonist to Treat Progressive Castrate Resistant Prostate Cancer (CRPC) treatment 2 unknown_status NCT03572946
Targeted Biopsy or Standard Biopsy for Clinical Significant Prostate Cancer Detection No drug interventions diagnostic Not Available unknown_status NCT05460312
Protein Kinase A in Prostate Cancer Tissue. No drug interventions Not Available Not Available not_yet_recruiting NCT06223295
Effectiveness of Focal Therapy in Men With Prostate Cancer No drug interventions treatment Not Available recruiting NCT06315595
Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion No drug interventions Not Available Not Available recruiting NCT03828838
Lutetium-177-PSMA-617 in Low Volume Metastatic Prostate Cancer treatment 1 / 2 completed NCT04792138
Learning MRI and Histology Image Mappings for Cancer Diagnosis and Prognosis. No drug interventions Not Available Not Available unknown_status NCT06020287
The Robot-Assisted Laparoscopic Radical Prostatectomy Combined Anterior and Posterior Approach No drug interventions Not Available Not Available completed NCT03819751
MRI-targeted Biopsy of the Prostate: Software Versus Visual Registration in the Accuracy of Prostate Cancer Detection No drug interventions diagnostic Not Available recruiting NCT01240551
F-18 Sodium Fluoride in Prostate Cancer diagnostic 2 completed NCT03431753
Early and Accurate Detection of Prostate Cancer in General Practice No drug interventions diagnostic Not Available unknown_status NCT03458598
Pre-Operative Single Shot Rectus Sheath Block No drug interventions treatment Not Available completed NCT05422105
Diagnostic Performance of 18F-PSMA-1007 PET/CT in Suspected Prostate Cancer Patient No drug interventions Not Available Not Available recruiting NCT04075305
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study No drug interventions Not Available Not Available recruiting NCT06292897
Using Tissue-based Spatial Data to Understand How Obesity-related Tumor Metabolites Fuel Prostate Cancer Progression No drug interventions Not Available Not Available recruiting NCT00805883
MRI Targeted Focal Laser Thermal Therapy of Prostate Cancer Followed by Radical Prostatectomy No drug interventions treatment 1 completed NCT05137561
Robotic-arm Assisted 68 Ga PSMA PET/CT Guided Prostate Biopsy Versus MR Directed TRUS Guided Prostate Biopsy No drug interventions diagnostic Not Available unknown_status NCT06430411
Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study Not Available Not Available not_yet_recruiting NCT03241537
COHORT Trial in Clinical Pelivc Lymph Node Metastatic Prostate Cancer No drug interventions treatment 3 active_not_recruiting NCT03321149
Reducing Sedentary Behavior Among Prostate Cancer Survivors on Androgen Deprivation Therapy No drug interventions supportive_care Not Available completed NCT05191017
Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC treatment 1 / 2 withdrawn NCT05373316
Addition of a Focal Boost in External Beam Radiotherapy for Locally Advanced Prostate Cancer by Online Adaptive MR-guided Radiotherapy No drug interventions treatment 2 not_yet_recruiting NCT00005916
PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate Cancer No drug interventions treatment 2 completed NCT03702439
Prostate Cancer Screening Trial Using Imaging No drug interventions Not Available Not Available completed NCT02436122
Impact of Preoperative HbA1c Levels on Pathologic Features and Oncological Outcomes in the Patients With Prostate Cancer No drug interventions Not Available Not Available unknown_status NCT00255125
Role of Soy Supplementation in Prostate Cancer Development No drug interventions prevention 3 completed NCT04019327
A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer treatment 1 / 2 active_not_recruiting NCT02380027
PRostate Evaluation for Clinically Important Disease: Sampling Using Image-guidance Or Not? No drug interventions diagnostic 3 completed NCT03822494
CyberKnife Dose Escalation Prostate Cancer Trial No drug interventions treatment Not Available recruiting NCT02225262
A Phase II Trial of CyberKnife Stereotactic Radiosurgery to Prostate Tumors No drug interventions treatment Not Available unknown_status NCT05710380
MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy No drug interventions screening Not Available recruiting NCT05276492
Decreasing Dosing Regimens of Abiraterone 500 mg in Men With Prostate Cancer to Find Lowest Recommended Dose. treatment 1 active_not_recruiting NCT03424850
Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy No drug interventions treatment 1 / 2 recruiting NCT04376008
A Prospective Study Of Free-Hand Transperineal Image Fusion Targeted Biopsies Under Local Anesthesia No drug interventions diagnostic Not Available completed NCT04030338
Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer No drug interventions Not Available Not Available active_not_recruiting NCT02362464
Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139 No drug interventions treatment 2 completed NCT03693703
Comparison of Multi-parametric and Bi-parametric Magnetic Resonance Imaging in Men With Suspicion of Prostate Cancer No drug interventions diagnostic Not Available completed NCT02311764
Carboplatin in Castration-resistant Prostate Cancer treatment 2 terminated NCT03389451
68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer diagnostic 2 / 3 completed NCT00252447
Preop Conformal Radiotherapy - Prostate No drug interventions treatment 1 / 2 completed NCT05849298
A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC treatment 2 recruiting NCT05129605
Prostate Cancer Genetic Risk Evaluation and Screening Study No drug interventions Not Available Not Available recruiting NCT03952793
Organoids From Metastases of Prostate Cancer No drug interventions basic_science Not Available terminated NCT04831307
68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical No drug interventions other Not Available unknown_status NCT03104907
Prostatic Artery Embolization for Obstructive Uropathy Due to Prostate Cancer No drug interventions treatment Not Available completed NCT03947515
Urinary and Prostate Microbiotes and Prostate Cancer No drug interventions basic_science Not Available completed NCT06059859
Impact of Augmented Reality During Robot-assisted Radical Prostatectomy No drug interventions treatment Not Available recruiting NCT01314118
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen treatment 2 active_not_recruiting NCT02967458
Detection of High Grade Prostate Cancer With Subharmonic Ultrasound Imaging, A Pilot Study diagnostic 2 completed NCT02966535
The Effect of Prolonged Inspiratory Time on Gas Exchange During Robot-assisted Laparoscopic Surgery With Steep Trendelenburg Position : A Crossover Randomized Clinical Trial No drug interventions treatment Not Available completed NCT00660686
Exercise for Physical Health in Men With Prostate Cancer No drug interventions supportive_care Not Available completed NCT01696539
Steps for PRosTAte Cancer Health and Survival (SPaRTACuS): Pilot Study of a Walking Intervention to Improve Health and Quality of Life in Prostate Cancer Patients No drug interventions supportive_care Not Available completed NCT03348722
Active Surveillance or Radical Treatment for Newly Diagnosed Patients With a Localized, Low Risk, Prostate Cancer START No drug interventions Not Available Not Available completed NCT04462926
Evaluation of Diagnostic Accuracy of [68Ga]Ga-PSMA-11 PET/CT in Primary Staging of Intermediate and High Risk Prostatic Cancer in Men Newly Diagnosed No drug interventions diagnostic Not Available recruiting NCT00666926
Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms No drug interventions treatment 1 completed NCT03242265
Measurement of Natural Killer Cell Activity in Whole Blood in Men Being Screened for Prostate Cancer With Biopsy No drug interventions screening Not Available terminated NCT06046131
Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression. No drug interventions other Not Available recruiting NCT04266431
EMPOWER Men to Reduce Weight and Inhibit Prostate Cancer Progression No drug interventions prevention Not Available active_not_recruiting NCT05162573
EBRT + Lu-PSMA for N1M0 Prostate Cancer treatment 1 recruiting NCT01540994
Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer No drug interventions treatment 1 / 2 completed NCT01431391
Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer treatment 2 completed NCT02526589
Does Bloody Urine Predict Urethrovesical Anastomosis Leakage After Radical Prostatectomy No drug interventions Not Available Not Available completed NCT06236789
Observation Study to Evaluate the Efficacy and Safety of Ifosfamide/Mesna in Patients With Metastatic Castration-resistant Prostate Cancer Not Available Not Available recruiting NCT03183544
Dosimetry and Safety Phase 1 Study With 68Ga-PSMA-11 Sterile Cold Kit No drug interventions diagnostic 1 completed NCT05968144
Towards Understanding Between ADT Treatment, Circadian Rhythm, and Physiological Responsiveness No drug interventions supportive_care 1 / 2 recruiting NCT00001444
A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms treatment 1 completed NCT04484701
[68Ga]Ga-PSMA-11 PET/CT in the Assessment of High Risk and Recurrent Prostate Cancer Not Available Not Available recruiting NCT00247312
Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial No drug interventions Not Available 3 completed NCT02687308
Open Anterograde Radical Prostatectomy Compared to Open Retrograde Technique No drug interventions treatment Not Available completed NCT03490838
177Lu-PSMA-R2 in Patients With PSMA Positive Progressive, Metastatic, Castration Resistant Prostate Cancer treatment 1 terminated NCT04854343
SLPI for Prostate Cancer No drug interventions Not Available Not Available unknown_status NCT03061643
An Open Label Phase II Study of Biweekly Docetaxel Plus Androgen-Deprivation Therapy in Patients With Previously-Untreated, Metastatic, Prostatic Adenocarcinoma treatment 2 unknown_status NCT02729103
Treatment Patterns in Metastatic Prostate Cancer Not Available Not Available completed NCT00751790
Efficacy and Safety of a Triptorelin 6-month Formulation in Patients With Advanced Prostate Cancer treatment 3 completed NCT03035487
Urology of Virginia Case Series No drug interventions device_feasibility Not Available completed NCT04774133
The Immunodynamic Effect of Radiotherapy in Prostate Cancer Patients. No drug interventions treatment Not Available unknown_status NCT00126854
High Field Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Brachytherapy Implantation No drug interventions diagnostic Not Available completed NCT05566405
The Effects of Method of Anaesthesia on the Safety and Effectiveness of Radical Retropubic Prostatectomy No drug interventions treatment Not Available completed NCT00956228
Study of Radioimmunoguided Intensity Modulated Radiotherapy (IMRT) for Prostate Cancer No drug interventions treatment 1 / 2 completed NCT04221828
Trial of NanoPac Focal Therapy for Prostate Cancer treatment 2 terminated NCT03343093
Restore: Improving Sexual Outcomes of Gay and Bisexual Prostate Cancer Survivors No drug interventions supportive_care Not Available completed NCT03693742
MSG Use With 18F-DCFPyL PET/CT Imaging No drug interventions diagnostic Not Available completed NCT04234399
Determination of the Diagnostic Detection Rate of Axumin (Fluciclovine) Digital PET/CT, Post-prostatectomy No drug interventions Not Available Not Available terminated NCT05667636
Early Salvage Stereotactic Radiotherapy for Biochemical Failure After RP No drug interventions treatment 2 recruiting NCT01337518
A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer No drug interventions treatment 1 suspended NCT05612841
A Study on Drug-drug Interactions in Patients Treated With Anticancer Agents for a Prostate Cancer in Real Life Setting No drug interventions Not Available Not Available recruiting NCT05786716
DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Teenage/Young Adult and Paediatric Patients With Cancers With HER2 Amplification or Activating Mutations treatment 2 / 3 recruiting NCT01996696
Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the Prostate treatment 2 terminated NCT04523896
HDR Brachytherapy Plus Stereotactic Ablative Prostate Radiotherapy for Patients With Intermediate and High-risk Prostate Cancer No drug interventions treatment 2 unknown_status NCT01316458
Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy treatment 2 completed NCT00174863
Evaluation of SR 31747A Versus Placebo in Androgen-Independent Non Metastatic Prostate Cancer No drug interventions treatment 2 completed NCT03397030
Impact of Exercise on Prognostic Biomarkers Related to Prostate Cancer No drug interventions treatment Not Available completed NCT03289130
Dietary Factors and Racial Disparities in Prostate Cancer Aggressiveness No drug interventions Not Available Not Available completed NCT00001266
A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate Carcinoma treatment 2 completed NCT03935282
Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors No drug interventions supportive_care Not Available active_not_recruiting NCT04398173
Detection Rate of Prostate Cancer in Men Undergoing MRI No drug interventions Not Available Not Available completed NCT01081873
Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative Therapeutic Approaches to the Treatments of Advanced Prostate Cancer Not Available Not Available completed NCT00252460
CT/MRI Co-registration Prostate Cancer No drug interventions Not Available Not Available completed NCT03939689
Study of I-131-1095 Radiotherapy in Combination With Enzalutamide in Patients With Metastatic Castration-resistant Prostate Cancer Who Are Chemotherapy Naive and Have Progressed on Abiraterone treatment 2 active_not_recruiting NCT03253744
Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy treatment 1 active_not_recruiting NCT03361969
Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist. treatment 2 completed NCT00001446
A Randomized Phase II Study of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer treatment 2 completed NCT03388346
68Ga PSMA in Preprostatectomy Patients diagnostic 2 / 3 completed NCT03982095
Survey on Lifestyle, Perceived Barriers and Development of Change in Patients With Prostate Cancer No drug interventions Not Available Not Available completed NCT02971995
Trimodal (18)F-choline-PET/mpMRI/TRUS Targeted Prostate Biopsies No drug interventions diagnostic Not Available completed NCT02977143
Positive End-expiratory Pressure-induced Increase in Central Venous Pressure as a Predictor of Fluid Responsiveness in Robot-assisted Laparoscopic Surgery No drug interventions diagnostic Not Available completed NCT00923221
Collection of Blood From Patients With Prostate Cancer No drug interventions Not Available Not Available recruiting NCT01834001
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy No drug interventions Not Available Not Available recruiting NCT03805919
Men at High Genetic Risk for Prostate Cancer No drug interventions Not Available Not Available recruiting NCT05616650
Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor treatment 2 recruiting NCT05872503
Study of Rates of Prostate Cancer Diagnosis in Men of African Ancestry Using MRI and MRI Guided Biopsy No drug interventions Not Available Not Available recruiting NCT06547398
Prostate Adaptive Radiation Therapy No drug interventions treatment Not Available not_yet_recruiting NCT04557059
A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer treatment 3 active_not_recruiting NCT04577833
A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate Cancer other 1 active_not_recruiting NCT04644770
A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer treatment 1 recruiting NCT04652973
Evaluation of Atherosclerotic Plaques in Abdominal CT Studies No drug interventions Not Available Not Available active_not_recruiting NCT04720157
An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With SoC, Versus SoC Alone, in Adult Male Patients With mHSPC treatment 3 recruiting NCT04736199
Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer treatment 3 active_not_recruiting NCT04898634
A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer No drug interventions treatment 1 recruiting NCT05022849
A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants No drug interventions other 1 active_not_recruiting NCT05288166
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer) treatment 3 active_not_recruiting NCT06608225
Prognostic Study of Prostate Cancer Via Dynamic Change of PSA in Peritoneal Drainage Fluid After Radical Prostatectomy No drug interventions Not Available Not Available not_yet_recruiting NCT06056830
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants with High-risk Prostate Cancer Prior to Radical Prostatectomy No drug interventions diagnostic 3 recruiting NCT06136650
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004) treatment 3 recruiting NCT06457854
Real-life Experience in Brazil in Patients With Castration-resistant Prostate Cancer Treated With Olaparib+Abiraterone No drug interventions Not Available Not Available not_yet_recruiting NCT06554639
A Drug-Drug Interaction Study of Diltiazem and MK-5684 in Healthy Adult Male Participants (MK-5684-011) treatment 1 completed NCT00485303
An Efficacy and Safety Study of Abiraterone Acetate and Prednisone in Participants With Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy treatment 2 completed NCT01306890
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer Not Available Not Available completed NCT01934790
Re-treatment Safety of Radium-223 Dichloride in Castration-resistant Prostate Cancer With Bone Metastases treatment 1 / 2 completed NCT05755490
PROWESS (PROstate Cancer Wearables Exercise and Structured Supports): A Pilot Supportive Care Intervention No drug interventions supportive_care Not Available not_yet_recruiting NCT02710721
Fasting and Nutritional Therapy in Patients With Advanced Metastatic Prostate Cancer No drug interventions supportive_care Not Available completed NCT03961321
Stereotactic MR-guided Adaptive Radiation Therapy for Localized Prostate Cancer No drug interventions Not Available Not Available completed NCT04248621
Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients supportive_care 4 unknown_status NCT01186484
Phase 1 Study of Abiraterone Acetate in Castration-resistant Prostate Cancer treatment 1 completed NCT00113984
Vaccine and Antibody Treatment of Prostate Cancer treatment 1 completed NCT02190279
18F-DCFBC PET/CT in Prostate Cancer diagnostic 0 completed NCT04573179
Effectiveness of 68Ga-PSMA PET/MRI for Improving the Detection of csPCa in Lesions With PI-RADS Score 3 No drug interventions Not Available Not Available unknown_status NCT03428087
Prostate Impendance Test Project No drug interventions Not Available Not Available unknown_status NCT00477087
Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate Cancer treatment 2 terminated NCT00271687
A Pilot Study of Exercise in Patients With Docetaxel-Based Chemotherapy for Hormone Refractory Prostate Cancer No drug interventions treatment 2 completed NCT03066154
Oral Docetaxel (ModraDoc/r) in Combination With Hormonal Treatment and Radiation Therapy in High-risk Prostate Cancer treatment 1 terminated NCT02362451
Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate Cancer No drug interventions treatment 2 terminated NCT00096551
A Phase I Feasibility Study of an Intraprostatic PSA-Based Vaccine in Men With Prostate Cancer With Local Failure Following Radiotherapy or Cryotherapy or Clinical Progression on Androgen Deprivation Therapy in the Absence of Local Definitive Therapy No drug interventions treatment 1 completed NCT00593853
Efficacy Study of Methylphenidate Hydrochloride to Reduce Fatigue in Prostate Cancer Patients Receiving Hormone Therapy treatment 2 terminated NCT00160953
Endorectal Coil Magnetic Resonance Images (ERC-MRI) No drug interventions prevention 2 completed NCT00569153
Safety Study of TAK-700 in Subjects With Prostate Cancer. treatment 1 / 2 completed NCT02341677
SmartTarget: BIOPSY No drug interventions diagnostic Not Available completed NCT02940977
Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection Technique No drug interventions Not Available Not Available unknown_status NCT00855647
Hypofractionated Radiotherapy for Localized Prostate Cancer (With CyberKnife or With IMRT) No drug interventions treatment 2 completed NCT05574647
Imperial Prostate 7 - Prostate Assessment Using Comparative Interventions - Fast Mri and Image-fusion for Cancer No drug interventions diagnostic Not Available recruiting NCT02266745
A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts treatment 2 active_not_recruiting NCT03822845
Evaluating the Clinical Accuracy of Gallium-68 PSMA PET/CT Imaging in Patients With Biochemical Recurrence of Prostate Cancer diagnostic 2 / 3 active_not_recruiting NCT05787145
ComCancer: Use of Let's Discuss Health Website by Patients With Prostate Cancer Undergoing Radiation Oncology Treatment No drug interventions other Not Available recruiting NCT00280098
Docetaxel in the Treatment of Hormone Refractory Prostate Cancer treatment 4 completed NCT00706498
Phase II Study of BI 2536 in Prostate Cancer treatment 2 completed NCT06136598
A Study of Opevesostat (MK-5684) in China Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (MK-5684-001) treatment 1 active_not_recruiting NCT00291005
PhII One Label Non-Comparative Trial in Metastatic Hormone Refractory Prostate Cancer in Combination With Prednisolone treatment 2 completed NCT00489905
Study on Evaluation of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate Cancer treatment Not Available completed NCT01918605
Protection of Rectum From High Radiation Doses Using a Spacer No drug interventions supportive_care Not Available terminated NCT03094897
Clinic Study of 18F-Al-NOTA-MATBBN in Cancer Diagnostics No drug interventions diagnostic 0 unknown_status NCT05228197
Imperial Prostate 6 - Cancer Histology Artificial Intelligence Reliability Study. No drug interventions Not Available Not Available recruiting NCT02526797
Multiparametric MRI in Men With Prostate Cancer Undergoing Active Surveillance No drug interventions Not Available Not Available enrolling_by_invitation NCT02151097
PRIME - PRostate Imaging for Margin Evaluation No drug interventions Not Available Not Available completed NCT00448097
Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before Prostatectomy treatment 2 terminated NCT02023697
Standard Dose Versus High Dose and Versus Extended Standard Dose Radium-223 Dichloride in Castration-resistant Prostate Cancer Metastatic to the Bone treatment 2 completed NCT01086683
Rehabilitation of Cancer Survivors in Denmark: The Effect of a Psychosocial Rehabilitation Course No drug interventions supportive_care 2 / 3 completed NCT02647983
Multiparametric MRI for Prostate Cancer Localization and Characterization Using Hyperpolarized Pyruvate (13C) Injection No drug interventions other 1 withdrawn NCT02290561
SmartTarget THERAPY No drug interventions treatment Not Available unknown_status NCT00564928
A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancer treatment 2 completed NCT01796028
Metformin-Docetaxel Association in Metastatic Hormone-refractory Prostate Cancer treatment 2 completed NCT00706628
A Multi-centre 3-arm Randomised Phase II Trial of BIBF 1120 Versus BIBW 2992 Versus Sequential Administration of BIBF 1120 and BIBW 2992 in Patients With Hormone-resistant Prostate Cancer treatment 2 completed NCT01288911
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer treatment 2 completed NCT00302471
MK0429 Study in Prostate Cancer Patients With Metastatic Bone Disease (0429-011) No drug interventions treatment 1 completed NCT04964271
Identification of Prostate Cancer Specific Markers in Patients Compared to Healthy Participants No drug interventions Not Available Not Available recruiting NCT00055471
A Phase IIa. Open-label, Multicenter, Dose-escalation Study to Assess the Tolerability and Pharmacokinetics of ZD4054 (Zibotentan) Given Orally Once Daily in Subjects With Metastatic Prostate Cancer treatment 2 completed NCT02443571
Retrospective Observational Study Investigating Fluciclovine (18F) (FACBC) No drug interventions Not Available Not Available completed NCT02043678
Radium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild Symptoms treatment 3 completed NCT00166478
Exisulind Prior to Radical Prostatectomy treatment 2 completed NCT04428788
Study to Evaluate the Safety and Tolerability of CC-94676 in Participants With Metastatic Castration-Resistant Prostate Cancer No drug interventions treatment 1 recruiting NCT00630188
Shared Decision Making for Prostate Cancer Screening: a Practice-Based Randomized Controlled Trial No drug interventions prevention Not Available completed NCT00692107
Radiotherapy for Prostate Cancer: Conventional Dose Versus High Dose No drug interventions treatment 3 completed NCT04523207
A Study of Apalutamide (Adjuvant Treatment) and Androgen Deprivation Therapy (ADT) in Participants Who Have Undergone Radical Prostatectomy (RP) for Non-metastatic Prostate Cancer and Who Are at High Risk for Metastases treatment 2 completed NCT00089609
Docetaxel, Thalidomide, Prednisone, and Bevacizumab to Treat Metastatic Prostate Cancer treatment 2 completed NCT02788409
Incidence of Second Primary Malignancies in Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the US No drug interventions Not Available Not Available completed NCT00448409
Activity of TroVax® Alone vs. TroVax® Plus GM-CSF in Patients With Prostate Cancer treatment 2 completed NCT01641185
Ion Prostate Irradiation No drug interventions treatment 2 completed NCT03587285
A Pilot Study of Hormonal Therapy Combined With Central Memory T Cells (Tcm) for Patients With Advanced Prostate Cancer treatment 1 / 2 unknown_status NCT00519285
Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer treatment 3 completed NCT05264337
Lymphedema After Urologic Surgery No drug interventions Not Available Not Available recruiting NCT03987737
Rectal Gas Removal Through Small Catheter Placement Prior to MRI of the Prostate No drug interventions diagnostic Not Available unknown_status NCT01550237
Curative Image Guided Radiotherapy for Prostate Cancer No drug interventions treatment Not Available active_not_recruiting NCT00822952
Prostate Mechanical Imager (PMI) Clinical Bridging Study No drug interventions Not Available Not Available completed NCT01173952
Quality of Life in Men Undergoing Robotic Assisted Laparoscopic Radical Prostatectomy Versus Radical Retropubic Prostatectomy No drug interventions Not Available Not Available unknown_status NCT01080352
Vitamin C as an Anti-cancer Drug treatment 2 completed NCT03021200
Laser Fluorescence in Cancer Surgical Treatment No drug interventions treatment Not Available unknown_status NCT04425200
Prevalence of HRR-related Genes Mutations and Prognosis in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients in Real World Setting No drug interventions Not Available Not Available completed NCT02230059
Study to Assess the Treatment Patterns in Metastatic Castration-Resistance Prostate Cancer (mCRPC) No drug interventions Not Available Not Available completed NCT03479359
Learning Curve of Digital Rectal Examination for Prostate Cancer Among Internship No drug interventions Not Available Not Available unknown_status NCT01024959
Clinical Evaluation of the PROGENSA(Registered Trademark) Prostate Cancer Gene 3 (PCA3) Assay in Men With a Previous Negative Biopsy Result No drug interventions diagnostic Not Available completed NCT01723475
First-in-man Dose Escalation Study of BAY2010112 in Patients With Prostate Cancer No drug interventions treatment 1 completed NCT04024475
Prostate Cancer Biobank No drug interventions Not Available Not Available active_not_recruiting NCT03824275
18F-DCFPyL Positron Emission Tomography (PET)/Computed Tomography (CT) in Men With Prostate Cancer No drug interventions diagnostic 2 / 3 active_not_recruiting NCT02963675
Incidence of Second Primary Malignancies in Prostate Cancer Patients With Bone Metastases - an Observational Retrospective Cohort Study in Sweden No drug interventions Not Available Not Available completed NCT05834270
Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH treatment Not Available completed NCT00188799
Xray Volume Imaging (Cone Beam CT) - Prostate Cancer No drug interventions treatment 2 completed NCT03261999
Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate (LMIS 25 mg) in Subjects With Prostate Cancer treatment 3 completed NCT04638049
Intestinal Microbiota in Prostate Cancer Patients as a Biomarker for Radiation-INduced Toxicity (IMPRINT) No drug interventions basic_science Not Available completed NCT02260349
Interest of Indocyanine Green in Neoplastic Prostatic Tissue diagnostic 3 withdrawn NCT00744549
Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance No drug interventions treatment 2 completed NCT01577836
Medico-economic Comparison of Robot-assisted Radical Prostatectomy Versus Radical Prostatectomy Via Laparotomy No drug interventions Not Available Not Available completed NCT02854436
An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies treatment 2 completed NCT01206036
CESAR Study in Prostate Cancer With Temsirolimus Added to Standard Docetaxel Therapy (CEPTAS) treatment 1 / 2 completed NCT04452136
Expanded Access Protocol of 68Ga PSMA 11 PET Imaging of Prostate Cancer Not Available Not Available approved_for_marketing NCT02508636
Trial of Radiotherapy With Leuprolide and Enzalutamide in High Risk Prostate Cancer treatment 2 terminated NCT01759836
Impact of Adjuvant Statin Therapy in Patients Who Underwent Radical Prostatectomy for Locally Advanced Prostate Cancer prevention 2 completed NCT00035113
EPO906 Therapy in Patients With Prostate Cancer treatment 2 completed NCT01441713
Treatment Frequency and Satisfaction in Patients With Advanced Prostate Cancer No drug interventions Not Available Not Available completed NCT00188513
Intensity Modulated Radiation Therapy - Prostate Cancer No drug interventions treatment 1 / 2 completed NCT02004418
A Study for Patients With Prostate Cancer to See Whether Delivering an Extra Dose of Radiation to Parts of the Body With More Cancer is Better Than Standard Treatment in Which the Same Dose of Radiation is Given Throughout the Prostate Gland No drug interventions treatment 1 / 2 completed NCT06151418
A Study to Learn About Novel Hormonal Therapies (NHTs) for Metastatic Castration-sensitive Prostate Cancer (mCSPC) in People Who Were in the Armed Forces Not Available Not Available active_not_recruiting NCT02182219
Oral Treatment With BIBF 1120 Together With Docetaxel and Prednisone in Patients With Hormone Refractory Prostate Cancer treatment 1 completed NCT03834519
Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010) treatment 3 completed NCT00080041
Study of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumors treatment 1 completed NCT00250224
Prostate Localization During Radiotherapy Using a Ni-Ti Stent and Electronic Portal Imaging - Protocol II No drug interventions treatment 1 completed NCT00253916
Exercise in Men Receiving Radiation Therapy for Prostate Cancer. No drug interventions prevention Not Available completed NCT00568516
Phase II Study of ASP3550 in Patients With Prostate Cancer treatment 2 completed NCT03237416
Drug-drug-interaction Study to Assess the Effect of Darolutamide on the Pharmacokinetics of Probe Substrates of CYP3A4 and P-gp in Healthy Male Volunteers other 1 completed NCT01464216
MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness No drug interventions Not Available Not Available active_not_recruiting NCT06072196
A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC) Not Available Not Available completed NCT00748358
An Open-label Phase II Study With SUTENT in Patients Suffering From Hormone Refractory Prostate Cancer treatment 2 completed NCT02123758
A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer treatment 1 active_not_recruiting NCT03241758
Vascular Changes Of Patients Undergoing Laparoscopic Radical Prostatectomy No drug interventions Not Available Not Available completed NCT01995058
Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer treatment 2 terminated NCT05918263
Exercise for Tumor Suppressive Impact in Black Men With Prostate Cancer on Active Surveillance: The REMOVE Trial No drug interventions supportive_care Not Available recruiting NCT00579163
Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers No drug interventions Not Available Not Available active_not_recruiting NCT00040586
Phase II Trial of Monoclonal Antibody (J591) in Combination With Low-Dose Subcutaneous Interleukin-2 treatment 2 completed NCT00230386
Role of Magnetic Resonance Imaging (MRI) Perfusion to Detect Disease in Prostate Carcinoma No drug interventions treatment 1 / 2 completed NCT03879486
Infectious Outcomes of Povidone-iodine Rectal Cleansing Plus Formalin Disinfection of Needle During Prostate Biopsy No drug interventions prevention Not Available completed NCT00546039
Synthetic Genistein (BONISTEIN™) in Patients Who Are Undergoing Surgery for Prostate Cancer basic_science 2 unknown_status NCT00406939
Vector Delivery of the IL-12 Gene in Men With Prostate Cancer No drug interventions treatment 1 completed NCT00705822
Combination of Docetaxel + Estramustine + Hydrocortisone Versus Docetaxel + Prednisone in Patients With Advanced Prostate Cancer treatment 3 terminated NCT00177125
Evaluating the Effect of the VCD on Erectile Function and Penile Length Post RRP No drug interventions prevention 3 completed NCT01653925
Molecular Mechanisms of Dutasteride and Dietary Interventions to Prevent Prostate Cancer and Reduce Its Progression prevention Not Available active_not_recruiting NCT00917748
Study With Modafinil in Patients Treated With Docetaxel-Based Chemotherapy for Metastatic Breast or Prostate Cancer (MOTIF) treatment 3 completed NCT01095848
A Phase I Safety Study of a Cancer Vaccine to Treat HLA-A2 Positive Advanced Stage Ovarian, Breast and Prostate Cancer No drug interventions treatment 1 completed NCT00930748
Evaluation of MRI for Prostate Cancer No drug interventions Not Available Not Available terminated NCT00482157
Calcitriol or Placebo in Men for Prostate Cancer Active Surveillance treatment Not Available withdrawn NCT02475057
Endothelial Function in Prostate Cancer Patients on Degarelix vs. Luteinizing Hormone-Releasing Hormone Agonists other 4 completed NCT02924766
A Safety and Pharmacokinetics Study of Niraparib Plus an Androgen Receptor-Targeted Therapy in Men With Metastatic Castration-Resistant Prostate Cancer (BEDIVERE) treatment 1 completed NCT06253065
Prospective Validation of Pathology-based Artificial Intelligence Diagnostic Model for Lymph Node Metastasis in Prostate Cancer No drug interventions Not Available Not Available recruiting NCT00040365
Amifostine to Protect the Rectum During External Beam Radiotherapy for Prostate Cancer supportive_care 2 completed NCT01423474
Prostate Accurately Targeted Radiotherapy Investigation of Overall Treatment Time No drug interventions treatment Not Available completed NCT05714774
Evaluation of Different Methods of Ultrasound Image Analysis for Real-time Monitoring of HIFU Prostate Cancer Treatment No drug interventions treatment Not Available recruiting NCT04839120
PK, PD, Tolerability and Safety of MDPK67b in Healthy Volunteers No drug interventions treatment 1 completed NCT00001382
A Phase I Study of Recombinant Vaccinia Virus That Expresses Prostate Specific Antigen in Adult Patients With Adenocarcinoma of the Prostate No drug interventions treatment 1 completed NCT02854982
Impact on Quality of Life 3 Years After Diagnosis of Prostate Cancer No drug interventions Not Available Not Available completed NCT00378482
A Rollover Study for Patients Who Received Tremelimumab in Other Protocols, to Allow the Patients Access to Tremelimumab Until This Agent Becomes Commercially Available or Development is Discontinued. treatment 2 completed NCT01545882
A Phase II Study of Degarelix in the Management of Non-Metastatic Hormone-Refractory Prostate Cancer treatment 2 terminated NCT02364531
A Canadian Observational Study in Metastatic Cancer of the Prostate: A Study of ZYTIGA Use in the Community Urology Setting No drug interventions Not Available Not Available completed NCT03501173
A Study of Participants With Advanced Prostate Cancer in Canada No drug interventions Not Available Not Available completed NCT03390127
Effect of PEEP on Arterial Oxygen Partial Pressure in Elderly Patients With Lithotomy Position Using LMA Supreme™ No drug interventions supportive_care Not Available completed NCT04907227
Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921)-China Extension treatment 3 terminated NCT02692976
Natural Dendritic Cells for Immunotherapy of Chemo-naive Metastatic Castration-resistant Prostate Cancer Patients No drug interventions treatment 2 completed NCT03101176
Multiparametric Ultrasound Imaging in Prostate Cancer diagnostic Not Available unknown_status NCT05022160
Preventing Catheter Related Bladder Discomfort (CRBD) With Bilateral Pudendal Nerve Block No drug interventions treatment 0 unknown_status NCT03315260
Treatment Satisfaction With Ra-223 in Japan Not Available Not Available completed NCT01683994
Cabozantinib Plus Docetaxel and Prednisone for Advanced Prostate Cancer treatment 1 / 2 completed NCT04085991
Two TraCer PositROn EmiSSion Tomography ComBination for Efficacy EstimatiOn of Prostate Specific Membrane Antigen Radioligand Therapy in Patients With Metastatic Prostate Cancer No drug interventions treatment 2 terminated NCT05123391
Randomized Pilot Study of Radiosurgery for the Treatment of Non-metastatic Prostate Cancer No drug interventions treatment Not Available recruiting NCT05670691
a Study of Combined mpMRI and PSMA PET/CT for Highly Suspicious Patients Performing Radical Prostatectomy Without Biopsy No drug interventions Not Available Not Available not_yet_recruiting NCT02772562
Adjuvant PROSTVAC-V/F in Subjects at High Risk for Relapse After Radical Prostatectomy No drug interventions treatment 2 completed NCT01976962
Functional MR-guided Stereotactic Body Radiation Therapy of Prostate Cancer No drug interventions treatment Not Available terminated NCT06379880
Impact on Quality of Life and Health of the CONTINUUM+ CONNECT Remote Monitoring Solution No drug interventions prevention Not Available recruiting NCT05068180
Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients No drug interventions prevention 4 unknown_status NCT00185029
MR-Lymphography and Lymph Node Staging in Prostate Cancer No drug interventions diagnostic 4 unknown_status NCT02053389
Testing Decision Aids About Early Stage Prostate Cancer No drug interventions health_services_research Not Available completed NCT00152789
Normal Prostate: Oxygenation of the Prostate Gland in Men Undergoing Prostate Biopsy No drug interventions diagnostic 2 completed NCT01685489
A Phase 1b Dose Escalation Trial of PSK®/Placebo With Docetaxel to Treat Metastatic Castration-resistant Prostate Cancer treatment 1 withdrawn NCT01647789
A Study of Oral CFG920 in Patients With Castration Resistant Prostate Cancer treatment 1 terminated NCT01711892
Health Effects of Soccer Training in Men With Prostate Cancer Receiving Androgen Deprivation Therapy No drug interventions supportive_care Not Available completed NCT03767244
A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy treatment 3 active_not_recruiting NCT02446444
Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer treatment 3 active_not_recruiting NCT00551044
Bicalutamide Monotherapy Has Significant Quality of Life Benefits for Men With Advanced Prostate Cancer treatment Not Available completed NCT04839367
Positron Emission Tomography (PET) Imaging of Participants With Confirmed Prostate Cancer Using 64Cu-SAR-bisPSMA (PROPELLER) No drug interventions diagnostic 1 completed NCT05335967
Effectiveness Evaluation of a Self-management Program for Prostate Cancer Survivors No drug interventions health_services_research Not Available recruiting NCT02344667
Feasibility Study of Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer: Cyberknife vs. VMAT No drug interventions treatment 2 unknown_status NCT05441501
A Study of JNJ-80038114 in Participants With Advanced Stage Prostate Cancer No drug interventions treatment 1 completed NCT00106301
Continuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Completed Prior Study With FK228 treatment 2 completed NCT02905201
A Prospective Compliance Registry for Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) No drug interventions Not Available Not Available withdrawn NCT01132404
Study in Men With Prostate Cancer to Assess the Safety, Pharmacokinetics and Testosterone-Lowering Efficacy of TAK-448 treatment 1 / 2 terminated NCT01821404
Atorvastatin Before Prostatectomy and Prostate Cancer prevention 2 completed NCT01981668
The JET Study: a Phase I Trial of Cabazitaxel, Radiotherapy and Long-term Androgen Deprivation treatment 1 withdrawn NCT02771769
Analysis of Cell-free DNA (cfDNA) in Men With Elevated PSA Levels No drug interventions Not Available Not Available terminated NCT00906269
Can Hyperbaric Oxygen Improve Erectile Function Following Surgery for Prostate Cancer treatment 4 unknown_status NCT02064946
High-dose Vitamin D Supplementation for ADT-induced Side Effects No drug interventions supportive_care Not Available completed NCT02899312
PSMA PET/CT for Assessment of Recurrent Prostate Cancer Not Available Not Available recruiting NCT01357512
Evaluation of Diagnostic Value of 3-T Magnetic Resonance Imaging (MRI) in Suspected Prostate Cancer No drug interventions diagnostic Not Available completed NCT04298112
PSMA-PET and MRI for Detection of Recurrent Prostate Cancer After Radical Treatment No drug interventions Not Available Not Available completed NCT00853710
Test Semiquantitative Prostate Specific Antigen (PSA) No drug interventions diagnostic Not Available completed NCT00268710
Docetaxel in Hormone Refractory Prostate Cancer (HRPC)[Weekly or 3weekly TAX + Prednisone in HRPC] treatment 2 completed NCT00064610
Phase I/II Dose Escalation Study of VELCADE® and Docetaxel in Patients With Advanced Androgen-Independent Prostate Cancer treatment 1 / 2 completed NCT02631681
Supervised Group Based Exercise for Men With Prostate Cancer on Androgen Deprivation Therapy No drug interventions treatment Not Available completed NCT00313781
Study of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC) treatment 2 completed NCT00521781
Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer treatment 2 terminated NCT02600481
Impacts of Different Pressure Pneumoperitoneum on Myocardial and Pulmonary Injuries After Robot-assisted Surgery No drug interventions treatment Not Available unknown_status NCT00121095
Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer treatment 1 / 2 unknown_status NCT03677414
Analysis of Androgene Receptors Axis and DNA Damage Repair Genes in Patients With Prostate Cancer No drug interventions Not Available Not Available unknown_status NCT02156414
Lymph Node Involvement Using Extended Pelvic Lymphadenectomy in Clinically Localized Prostate Cancer No drug interventions Not Available Not Available completed NCT00900614
Safety Study of APR-246 in Patients With Refractory Hematologic Cancer or Prostate Cancer treatment 1 completed NCT02506114
Neoadjuvant PROSTVAC-VF With or Without Ipilimumab for Prostate Cancer treatment 2 terminated NCT05413850
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection treatment 1 / 2 recruiting NCT00676650
Sunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel Chemotherapy treatment 3 terminated NCT01681823
Effect of Modified Citrus Pectin on PSA Kinetics in Biochemical Relapsed PC With Serial Increases in PSA No drug interventions treatment 2 completed NCT00450008
Safety and Efficacy Study of GM-CSF, Thalidomide Plus Docetaxel in Prostate Cancer treatment 2 terminated NCT02813408
A Study to Investigate the Impact of Abiraterone Acetate and Enzalutamide on Health-related Quality of Life, Participant-Reported Outcomes, and Medical Resource Use in Metastatic Castration-resistant Prostate Cancer Participants No drug interventions Not Available Not Available completed NCT00976508
Figitumumab Combined With Pegvisomant For Advanced Solid Tumors treatment 1 terminated NCT02702908
Second Primary Cancers in Patients With Castration Resistant Prostate Cancer No drug interventions Not Available Not Available completed NCT01522443
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer treatment 3 terminated NCT02076503
Pre-operative PET-MR of High Risk Prostate Cancer Patients for Assessment of Cancer Aggressiveness and Lymph Node Status No drug interventions diagnostic Not Available completed NCT02621190
Cabazitaxel in mCRPC Patients With AR-V7 Positive CTCs diagnostic 2 withdrawn NCT00638690
Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy treatment 3 completed NCT02950064
A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations No drug interventions treatment 1 unknown_status NCT02138721
Local Treatment With RP for Newly-diagnosed mPCa No drug interventions treatment Not Available recruiting NCT00403221
Phase I - Pre-Radical Prostatectomy RTVP-1 Gene Therapy for Prostate Cancer No drug interventions treatment 1 completed NCT02526602
Preservation of Endopelvic Fascia: Effects on Postoperative Incontinence and Impotence. Randomized Clinical Trial. No drug interventions treatment Not Available completed NCT02043184
Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR No drug interventions supportive_care Not Available completed NCT00160979
Transrectal Tumour Oxygen - US Army No drug interventions diagnostic 2 completed NCT00417079
XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer treatment 3 completed NCT00031187
Study of SGN-15, Antibody-Drug Conjugate, to Treat Hormone Refractory Prostate Cancer treatment 2 completed NCT00383487
A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer treatment 2 terminated NCT00050687
Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies treatment 1 / 2 terminated NCT00056654
Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer treatment Not Available completed NCT02560051
Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer treatment 2 terminated NCT01076751
Observational Registry of Treatment Patterns in Castrate-resistant Prostate Cancer (CRPC) Patients No drug interventions Not Available Not Available terminated NCT01377753
MR Image Guided Therapy in Prostate Cancer No drug interventions treatment 2 completed NCT06209853
Correlation Between PSA Levels and F-18 PSMA PET/CT Findings in Prostate Cancer Patient No drug interventions Not Available Not Available recruiting NCT02102477
Surgery Versus Radiotherapy for Locally Advanced Prostate Cancer No drug interventions treatment Not Available recruiting NCT00001377
Familial Prostate Cancer No drug interventions Not Available Not Available completed NCT05851547
Dose Escalation For INtraprostatic LEsions treatment 2 recruiting NCT04295447
Adjuvant Apalutamide in Subjects With High-risk Localized or Locally Advanced Prostate Cancer After Radical Prostatectomy treatment 2 active_not_recruiting NCT00476645
Fulvestrant in Hormone Refractory Prostate Cancer treatment 2 completed NCT03436745
The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy Females basic_science 1 completed NCT03533998
Biomarkers in Prostate Cancer Treated With SRP Following Failure of FAT No drug interventions Not Available Not Available unknown_status NCT04101305
Measurement of Circulating Tumor Cells in Prostate Cancer No drug interventions Not Available Not Available unknown_status NCT01020305
Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer treatment 1 / 2 terminated NCT02446405
Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer treatment 3 active_not_recruiting NCT00744497
Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancer treatment 3 completed NCT01450683
Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapy treatment 2 terminated NCT00060528
Sequential Vaccinations in Prostate Cancer Patients No drug interventions treatment 1 / 2 completed NCT04689828
177Lu-PSMA-617 vs. Androgen Receptor-directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer treatment 3 active_not_recruiting NCT04033328
Study of ORIC-101 in Combination With Enzalutamide treatment 1 terminated NCT03834493
Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641) treatment 3 active_not_recruiting NCT00039793
Massage Therapy for Cancer-Related Fatigue No drug interventions treatment 2 completed NCT00861471
Docetaxel (Taxotere) and Imatinib Mesylate (Gleevec) in Hormone Refractory Prostate Cancer treatment 1 / 2 terminated NCT02284971
Pilot Study of SBRT and CDX-1127 in Prostate Cancer treatment 1 terminated NCT02718378
Evaluation of Safety and Efficacy of Estetrol in Healthy Men basic_science 1 completed NCT04628988
A Study of CC-90011 and Comparators in Participants With Prostate Cancer treatment 1 completed NCT01802307
Focal Therapy for Prostate Cancer No drug interventions treatment 2 withdrawn NCT02453009
Addition of Enzalutamide to First Line Docetaxel for Castration Resistant Prostate Cancer treatment 2 completed NCT04461509
High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy other 2 active_not_recruiting NCT00672009
A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer treatment 2 terminated NCT00036556
Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer treatment 3 completed NCT00452556
The ELDORADO (Eligard®, Docetaxel and Radiotherapy) Study treatment 2 unknown_status NCT06282185
SUPERvised Three-month Exercise Program in MEN With Prostate cAncer Receiving Androgen-deprivaTioN thERapy No drug interventions treatment Not Available suspended NCT02616185
A Phase 1 Study To Evaluate Escalating Doses Of A Vaccine-Based Immunotherapy Regimen For Prostate Cancer (PrCa VBIR) treatment 1 terminated NCT02234115
Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate Carcinoma treatment 3 completed NCT03421015
Genetic Analysis of Prostate Cancer to Identify Predictive Markers of Disease Relapse or Metastatic Evolution No drug interventions Not Available Not Available unknown_status NCT00070837
MLN2704 in Subjects With Metastatic Androgen-Independent Prostate Cancer treatment 1 / 2 completed NCT05902637
The Efficacy Of Mapping For Cognitive Prostate Biopsy No drug interventions diagnostic Not Available recruiting NCT02014337
Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors treatment 1 completed NCT00667537
PK in Pts With HRPC & Skeletal Metastes basic_science 1 completed NCT03553732
An Electronic Registry to Improve Adherence to Active Surveillance Monitoring at a Safety-net Hospital No drug interventions Not Available Not Available terminated NCT03007732
Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADT treatment 2 active_not_recruiting NCT02034552
A Randomized Phase IIa Efficacy and Safety Study of Radium-223 Dichloride With Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CRPC) treatment 2 completed NCT02338700
Safety and Efficacy Study of Mix Vaccine in Prostate Carcinoma Patient No drug interventions treatment 1 / 2 completed NCT02584400
Tumor Hypoxia With HX4 PET in Several Diseases No drug interventions diagnostic 2 terminated NCT05765500
RecoverPC: Relugolix vs GnRH Agonist in Quality of Life treatment 2 recruiting NCT00048659
YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy No drug interventions treatment 2 terminated NCT04983459
PSMA PET/CT for Biochemical Recurrence Detection in Patients With Prostate Cancer No drug interventions Not Available Not Available completed NCT03648359
Multiparametric MRI in Men With Prostate Cancer Enrolled in Active Surveillance No drug interventions diagnostic Not Available enrolling_by_invitation NCT01991275
Intrathecal Morphine in Robot-assisted Prostatectomy treatment Not Available completed NCT04093375
Radical Prostatectomy Versus Radical Radiotherapy for Locally Advanced Prostate Cancer No drug interventions treatment Not Available not_yet_recruiting NCT01618370
Radium(223) Dichloride (Alpharadin) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases treatment 3 completed NCT01810770
Radium-223 Dichloride Asian Population Study in the Treatment of CRPC Patients With Bone Metastasis treatment 3 completed NCT00040170
Vaccine Study of MVA-MUC1-IL2 in Patients With Prostate Cancer treatment 2 terminated NCT03523442
A Study of Androgen Receptor (AR) Antagonist Apalutamide in Chinese Participants With Metastatic Castration-Resistant Prostate Cancer treatment 1 active_not_recruiting NCT01913106
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer treatment 1 / 2 recruiting NCT03834506
Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921) treatment 3 completed NCT04836949
Verification of Shear Wave Elastography for DEtection of Prostate Cancer No drug interventions diagnostic Not Available unknown_status NCT06104449
A Study of Opevesostat (MK-568)4 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005) treatment 1 active_not_recruiting NCT02430649
Irreversible Electroporation(IRE) For Unresectable Prostatic Neoplasms No drug interventions treatment Not Available withdrawn NCT02381236
G-202 in the Neoadjuvant Setting Followed by Radical Prostatectomy in Patients With Prostate Cancer treatment 2 completed NCT00381836
Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate Cancer supportive_care 2 / 3 terminated NCT00446836
Efficacy and Safety Study of Xyotax to Treat Prostate Cancer treatment 2 completed NCT00137436
Study Of SU011248 In Combination With Docetaxel (Taxotere) And Prednisone In Patients With Prostate Cancer treatment 1 / 2 completed NCT02257736
An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC) treatment 3 active_not_recruiting NCT05150236
EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPC treatment 2 active_not_recruiting NCT00878436
Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration treatment 1 / 2 completed NCT05266313
Contributions of a Paramedical Approach in the Prevention and Treatment of Side Effects Associated With Radical Prostatectomy No drug interventions supportive_care Not Available active_not_recruiting NCT04838613
Study of Diagnostic Performance of [18F]CTT1057 in BCR diagnostic 3 completed NCT02668718
Adjuvant Radiation Therapy vs. Watchful Waiting Following Radical Prostatectomy in High Risk Prostate Cancer No drug interventions treatment 3 unknown_status NCT03365518
Innovations in the Treatment of Sexual Health Post Prostate Cancer Treatment: Comparing Mindfulness vs. CBT No drug interventions supportive_care Not Available completed NCT00177619
Prevention of Osteoporosis in Men With Prostate Cancer on Androgen Deprivation Therapy (POP Study) treatment 3 completed NCT00152919
Mobicox: Study of Meloxicam to Reduce Prostate Swelling in Permanent Seed Prostate Brachytherapy treatment 3 completed NCT06242119
Clinical Application of the J-PET Scanner Prototype No drug interventions Not Available Not Available recruiting NCT01296217
Sentinel Lymph Node Detection in Prostate Surgery by Laparoscopy No drug interventions Not Available Not Available completed NCT02125617
Urokinase Plasminogen Activator Receptor in Abiraterone Treated Patients With Castration Resistant Prostate Cancer Not Available Not Available terminated NCT01857817
Efficacy and Safety Study of Etodolac and Propranolol in Patients With Clinically Progressive Prostate Cancer treatment 2 terminated NCT00514917
A Study of Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Participants With a Rising Prostate Specific Antigen (PSA) treatment 3 terminated NCT02744534
Targeted Fusion Biopsy of the Prostate No drug interventions diagnostic 2 completed NCT00182624
Magnetic Resonance Imaging to Evaluate Prostate Cancer No drug interventions Not Available Not Available completed NCT01962324
Dose Escalation With SIB to Intraprostatic/Lymphatic GTV in High Risk Prostate Cancer No drug interventions treatment Not Available completed NCT02943824
Machine-learning Optimization for Prostate Brachytherapy Planning No drug interventions other Not Available completed NCT03481816
Treatment of Castration Resistant Prostate Cancer Using Multi-Targeted Recombinant Ad5 PSA/MUC1/Brachyury Based Immunotherapy Vaccines treatment 1 completed NCT03827616
Moderately Hypofractionated Radiotherapy for Prostate Cancer. No drug interventions treatment 2 enrolling_by_invitation NCT02531516
An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS treatment 3 active_not_recruiting NCT02631616
Treatment With Sandostatin in Patients With Castrate Resistance Prostate Cancer Showing Uptake of 68Ga-DOTATET treatment 1 unknown_status NCT02651896
Hypofractionated Intensity Modulated and Image Guided Radiotherapy for Localized Prostate Cancer No drug interventions Not Available Not Available unknown_status NCT00061035
Evaluation of Transgenic Lymphocyte Immunization Vaccine in Subjects With Prostate Adenocarcinoma No drug interventions treatment 1 completed NCT05506735
The Role of the Seven Sweeps in the Prevention of the Prostate Cancer Among Those With a Positive Family History No drug interventions Not Available Not Available completed NCT03565835
Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate Cancer treatment 2 unknown_status NCT06433063
Effect of Hypoxia on FMISO PET to Response to Lu-177 PSMA Treatment No drug interventions diagnostic Not Available recruiting NCT02182063
A Study With BIBF 1120 in Patients With Hormone Refractory Prostate Cancer treatment 2 completed NCT01955863
Outpatient Radical Prostatectomy - Surgical and Anesthetic Considerations No drug interventions treatment Not Available completed NCT00188786
Cone Beam CT for Daily Image Guidance - Prostate Cancer No drug interventions treatment 2 completed NCT00436839
Taxotere Prostate Cancer New Indication Registration Trial in China treatment 3 completed NCT00817739
Intermittent Hormonal Therapy With Leuprorelin and Flutamide in the Treatment of Stage D2 or TxNxM1b,c treatment 2 completed NCT00120939
Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer treatment 1 completed NCT00032825
Ketoconazole Plus Docetaxel to Treat Prostate Cancer treatment 1 completed NCT02391025
Gallium-68 Citrate PET Used in Prostate Cancer diagnostic 0 completed NCT02233725
MRI / Ultrasound Fusion With Contrast-Enhanced Ultrasound Guidance No drug interventions diagnostic 1 unknown_status NCT02079025
Multi-Center Trial of High-resolution Transrectal Ultrasound Versus Standard Low-resolution Transrectal Ultrasound for the Identification of Clinically Significant Prostate Cancer No drug interventions other Not Available completed NCT01816048
NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasis treatment 2 terminated NCT02672657
Determinants of Quality Of Life in AGEd Cancer Patients No drug interventions Not Available Not Available unknown_status NCT01198457
Study to Investigate Adherence of Patients to Clodronate (Bonefos) Treatment Not Available Not Available completed NCT03119857
Early Rising PSA Endocrine Treatment Versus Chemo-endocrine Therapy- SPCG14 treatment 3 unknown_status NCT04838626
Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection diagnostic 2 / 3 completed NCT04833426
Impact of Peri-operative tEstosterone Levels on oNcological and Functional Outcomes in RadiCal prostatEctomy treatment 3 recruiting NCT00110526
Gene Therapy for Prostate Cancer That Returns After Radiation Therapy No drug interventions treatment 1 withdrawn NCT01443026
The Effects of Lycopene on High Risk Prostatic Tissue prevention 2 completed NCT00166426
Exisulind Versus Placebo After Surgical Removal of the Prostate prevention 2 completed NCT02217566
Study of Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC), Chemo-Naive, Who Received a Prior Diethylstilbestrol Therapy treatment 2 completed NCT03600766
Mirabegron for Treatment of Erectile Dysfunction in Patients With LUTS Secondry to BPH: A Randomized Study treatment 2 unknown_status NCT00127465
Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their Confidants No drug interventions Not Available 1 / 2 completed NCT00401765
A Study of CNTO 328 in Patients With Metastatic Hormone-Refractory Prostate Cancer treatment 1 completed NCT01420965
Sipuleucel-T, CT-011, and Cyclophosphamide for Advanced Prostate Cancer treatment 2 terminated NCT00756665
Prostate Active Surveillance Study No drug interventions Not Available Not Available recruiting NCT00521274
Study of Trovax® Plus Docetaxel Versus Docetaxel Alone in Patients With Progressive Hormone Refractory Prostate Cancer treatment 2 terminated NCT02831920
CEUS Targeted Biopsies Compared to mpMRI Targeted and Systematic Biopsies for the Detection of Prostate Cancer No drug interventions diagnostic Not Available unknown_status NCT00573820
Far Infrared Radiation Treatment for Prostate Cancer No drug interventions treatment 1 unknown_status NCT02712320
Open-Label Safety Extension Study in Patients Who Have Previously Participated and Have Benefited From LMIS 50 mg No drug interventions treatment 3 completed NCT02245282
Contrast Enhanced MRI of the Prostate No drug interventions Not Available Not Available completed NCT01446731
Dendritic Cell Vaccination and Docetaxel for Patients With Prostate Cancer treatment 2 completed NCT00447473
Trial of GM-CSF Given in Combination With Ketoconazole and Mitoxantrone in Patients With Progressive Prostate Cancer treatment 2 terminated NCT05295927
A Study of EPI-7386 in Combination With Abiraterone Acetate Plus Prednisone, or Apalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) treatment 1 terminated NCT01605227
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100 treatment 3 completed NCT02668276
Engaging Newly Diagnosed Men About Cancer Treatment Options No drug interventions other Not Available completed NCT02677376
Imaging Biomarkers to Validate Response in Enzalutamide-Treated mCRPC No drug interventions Not Available Not Available completed NCT01347476
Aggressive Prostate Cancers in Elderly Patients No drug interventions Not Available Not Available completed NCT05633160
64Cu-SAR-BBN and 67CU SAR-BBN for Identification and Treatment of Gastrin Releasing Peptide Receptor (GRPR)-Expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617 (COMBAT) No drug interventions treatment 1 / 2 recruiting NCT04521894
The Application Value of 18F-prostate-specific Membrane Antigen PET/CT in Prostate Cancer No drug interventions Not Available Not Available recruiting NCT00235794
An Open Label Exploratory Study in Newly Diagnosed Prostate Cancer Patients prevention Not Available completed NCT00962494
Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors No drug interventions supportive_care 2 completed NCT02869594
Institut Paoli Calmettes Prostate Cancer Database No drug interventions Not Available Not Available recruiting NCT02563691
Stereotactic Radiotherapy for Oligometastatic Prostate Cancer No drug interventions treatment 1 / 2 unknown_status NCT01717391
[F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers No drug interventions treatment 2 completed NCT00038662
Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure treatment 2 completed NCT03526562
Exercise Prescription Dose for Castration Resistance Prostate Cancer Patients No drug interventions treatment Not Available completed NCT00283062
Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy treatment 3 completed NCT01516762
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases Not Available Not Available no_longer_available NCT01640262
Evaluation of Modern MRI in the Diagnosis of Prostate Cancer in a Danish Setup No drug interventions Not Available Not Available completed NCT01023529
Symptoms and Quality of Life (QoL) After Palliative Pelvic Radiation of Prostate and Rectal Cancers No drug interventions Not Available Not Available completed NCT01576029
Continued Treatment With Docetaxel Versus Switch to Cabazitaxel After Minor Prostate Specific Antigen Response to Docetaxel in Patients With Castration-Resistant Metastatic Prostate Cancer treatment 2 completed NCT04430192
Dosimetry, Safety and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomy treatment 1 / 2 active_not_recruiting NCT00844792
Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer No drug interventions treatment 2 completed NCT00075192
CP-675,206 With Neoadjuvant Hormone Therapy in Patients With High Risk Prostate Cancer treatment 1 / 2 completed NCT00007540
Study of Prostate Cancer in Black and White U.S. Veterans No drug interventions Not Available Not Available completed NCT00446901
Selenium and Prostate Cancer: Clinical Trial on Availability to Prostate Tissue and Effects on Gene Expression No drug interventions prevention Not Available completed NCT04967001
68Ga-PSMA PET in the Prostate Cancer No drug interventions diagnostic Not Available recruiting NCT05958004
The Application Value of Prostate Specific Membrane Antigen PET/CT in Biopsy Free of PSA Grey Area Prostate Cancer No drug interventions Not Available Not Available completed NCT04017104
Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging No drug interventions Not Available Not Available unknown_status NCT02919904
Feasibility Study for the Assessment of Sleep Quality in Men With Prostate Cancer Starting ADT No drug interventions Not Available Not Available completed NCT05941104
The Effect of Frailty on Blood Biology Indicators, Quality of Life and Survival of Patients With Radical Prostatectomy No drug interventions Not Available Not Available not_yet_recruiting NCT01946204
A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer treatment 3 active_not_recruiting NCT01335204
Ph Ib/IIa Study of Cabazitaxel Plus Bavituximab in Castration-resistant Prostate Cancer treatment 1 / 2 terminated NCT01261572
Study to Find Maintenance Dose for Periodic Administration of ASP3550 treatment 2 completed NCT05999968
Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment treatment 1 active_not_recruiting NCT04790968
Combined PSMA PET/MRI for Detection of Lymph Node Metastases in High-risk Prostate Cancer Patients No drug interventions diagnostic Not Available recruiting NCT04854369
68Ga-PSMA-11 Patients With Newly Diagnosed and Recurrent Prostate Cancer (Firefly) No drug interventions Not Available Not Available no_longer_available NCT02952469
Biodistribution/Reproducibility Ga-68 PSMA-HBED-CC diagnostic 0 completed NCT02632669
Hemi-Ablative Prostate Brachytherapy No drug interventions treatment Not Available completed NCT01565746
Safety, Biodistribution, Radiation Dosimetry and Pharmacokinetics Study of BAY88-8223 in Japanese Patients treatment 1 completed NCT02283346
Single Fraction HDR Brachytherapy Plus Hypofractionated EBRT for Low-risk Prostate Cancer: Phase II Trial No drug interventions treatment 2 unknown_status NCT00473512
A Safety and Efficacy Study of Abiraterone Acetate in Participants With Prostate Cancer Who Have Failed Hormone Therapy treatment 1 / 2 completed NCT04693910
Multimedia-based Hormonal Therapy Information Program for Patients With Prostate Cancer No drug interventions health_services_research Not Available completed NCT00537381
An Efficacy and Safety Study of Intetumumab (CNTO 95) in Participants With Metastatic Hormone Refractory Prostate Cancer treatment 2 completed NCT00188695
Combidex USPIO - Ultra-small Superparamagnetic Iron Oxide No drug interventions diagnostic 1 / 2 completed NCT04034095
A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan Not Available Not Available active_not_recruiting NCT02363855
Phase 1 Dose Escalation Study of BAY 1841788 in Japanese Metastatic Castration-resistant Prostate Cancer (mCRPC) Subjects treatment 1 completed NCT01929655
Japanese BAY88-8223 Monotherapy Phase II Study treatment 2 completed NCT02606123
Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate Cancer No drug interventions treatment 1 / 2 terminated NCT03064308
The Assessment of the Feasibility of a Home Based Exercise Programme in the Older Patient Following Major Surgery No drug interventions other Not Available completed NCT02546908
A Registry of Participants With Prostate Cancer in Asia No drug interventions Not Available Not Available completed NCT04108208
A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC) treatment 4 active_not_recruiting NCT00188708
Effect of Casodex on Tumour Hypoxia - Prostate Cancer No drug interventions diagnostic Not Available completed NCT00373308
Quality of Life Following Radical Prostatectomy No drug interventions Not Available Not Available completed NCT02833038
Effect of Intravenous Magnesium During Robot Assisted Prostatectomy prevention Not Available completed NCT03523338
An Expanded Access Protocol for Apalutamide Treatment of Participants With Non-Metastatic Castration-Resistant Prostate Cancer Not Available Not Available no_longer_available NCT00230438
External Beam Radiation Therapy - Target Volume No drug interventions treatment 2 completed NCT00242138
Erectile Dysfunction/Prostate/RT/Androgen No drug interventions Not Available 2 completed NCT01365143
Prospective Randomized Trial Comparing Robotic Versus Open Radical Prostatectomy No drug interventions treatment 4 terminated